CCEPH Investigators Honored for Contribution to Vaccine Safety (November 2015)
Two investigators, James Donahue, DVM, PhD, and Edward Belongia, MD, from the Center for Clinical Epidemiology and Population Health (CCEPH) were honored for their contributions to vaccine safety research. Awards were presented at the annual meeting for the Vaccine Safety Datalink (VSD) in November 2015. VSD is a collaborative project between the U.S. Centers for Disease Control and Prevention (CDC) and nine health care organizations, including Marshfield Clinic Health System.
'Letter to the Editor' in the New York Times (July 2015)
Edward Belongia, MD, Director of the Center for Clinical Epidemiology and Population Health (CCEPH) at the Marshfield Clinic Research Institute (MCRI), was quoted in a New York Times story about a panel's decision to recommend the meningitis vaccine for certain people. Dr. Belongia, an expert on vaccines, is a member of the Advisory Committee on Immunization Practices (ACIP). The independent panel makes recommendations to the U.S. Government regarding vaccine use. Dr. Belongia also submitted a letter to the editor of the New York Times, which provides additional context.
2014-2015 Flu Vaccine Effectiveness (January 2015)
Edward Belongia, MD, Director of the Center for Clinical Epidemiology and Population Health (CCEPH), was featured in numerous stories about the effectiveness of this year’s flu vaccine. Along with media interviews (Marshfield News Herald, WSAW), Dr. Belongia served as an expert source for the Canadian Press, which distributes news stories throughout Canada. For more information pertaining to CDC's (Centers for Disease Control and Prevention) interim report on this year’s flu vaccine effectiveness, visit ABC News and the CDC Morbidity and Mortality Weekly Report.
Grant Received by CCEPH to Raise Awareness for HPV Vaccination (January 2015)
Center for Clinical Epidemiology and Population Health (CCEPH) Researchers received a $620,000 grant from Centers for Disease Control and Prevention (CDC) to help educate the public about the human papillomavirus (HPV) and to improve HPV vaccination rates among adolescents.